Research and Markets: It's Time to Tackle the High Cost of Overweight and Obesity

August 12, 2005 (PRLEAP.COM) Health News
Dublin - Research and Markets (http://www.researchandmarkets.com/reports/c22293) has announced the addition of Obesity: Disease Management Strategies & Programs TM to their offering

Health care organizations across the country are slashing unnecessary utilization and costs, increasing patient satisfaction, and improving health behaviors and outcomes with disease management programs targeted at high-cost, chronic illnesses.

With the Disease Management Series of special reports, your organization can benefit from the experience of health providers and plans that already have successful disease management programs in place.

Each report in the series is full of detailed case studies; practical advice on developing and implementing your programs; valuable data on costs, utilization, and outcomes; and tools such as pathways, assessment forms, guidelines, checklists, and more.

Topics covered:-

- It's time to tackle the high cost of overweight and obesity
- Tackling the challenge of obesity in children and adolescents
- Obesity epidemic creates demand for online solutions
- Financial implications of obesity weigh heavily on providers, plans
- Epidemic of obesity fuels demand among payers for alternatives to bariatric surgery
- Coaching model proves effective for obesity DM
- Study quantifies impact of obesity on health care costs
- HealthPartners battles excess pounds on a population basis
- Kaiser mimics stop smoking programs in building its weight control strategy
- CDC heads new collaborative focused on attacking obesity
- Upsurge in weight loss surgery presents new opportunities for DM behavioral approach
- Disease managers urged to focus on epidemic of obesity
- Roche turns to DM to boost patient compliance with its weight loss drug
- Magellan makes first splash in DM pool: obesity management
- Obesity redux: Beware health care costs of obese members aging in place
- Obesity expensive, but is it a clinical priority?

Companies mentioned:

- HealthPartners
- Kaiser
- CDC
- Roche
- Magellan

For more information visit http://www.researchandmarkets.com/reports/c22293

Laura Wood
Senior Manager
Research and Markets
press@researchandmarkets.com
Fax: +353 1 4100 980